The US Food and Drug Administration's perspective on the new antidepressant vortioxetine
J Zhang, MV Mathis, JW Sellers… - The Journal of …, 2014 - psychiatrist.com
Objective: This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …
The US Food and Drug Administration's perspective on the new antidepressant vortioxetine.
J Zhang, MV Mathis, JW Sellers… - The Journal of …, 2015 - europepmc.org
Objective This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …
The US Food and Drug Administration's perspective on the new antidepressant vortioxetine
J Zhang, MV Mathis, JW Sellers… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …
on the New Antidepressant Vortioxetine
J Zhang, MV Mathis, JW Sellers, G Kordzakhia… - J Clin …, 2015 - psychiatrist.com
Objective: This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …